Extended Data Table 1. Validation of mutation calling.
To determine validation rate for mutation calling, a custom capture SureSelect design was used to sequence selected coding/non-coding loci to an average depth of 360-2000X. For loci with sufficient depth (>=20X), the validation rate (the proportion of somatic variants) was calculated as described in Extended Data Table 2 and Supplementary Information, section 3c. On average 95% and 86% of the substitutions and indels, respectively, were somatic. Validation for rearrangement calls was performed by PCR-gel electrophoresis, as described in Supplementary Information, section 3d. PCR-gel experiments yielded a high validation rate for three of the four patients included in the validation. For A22, there was a high rate of PCR failure. For this sample, we therefore assessed the veracity of the breakpoints by visual inspection of the associated copy number segments and confirmed that 82% were high-confidence events resulting in visible copy number changes.
Patient | # coding subs | # subs from mutation clusters | # total unique subs | # subs with coverage* | % somatic | |
| ||||||
substitutions | A10 | 109 | 163 | 270 | 269 | 90.70% |
A22 | 97 | 265 | 356 | 356 | 98.60% | |
A29 | 76 | 70 | 144 | 143 | 93.00% | |
A31 | 43 | 109 | 150 | 150 | 89.30% | |
A32 | 74 | 388 | 450 | 450 | 97.80% | |
A12 | 54 | 144 | 192 | 191 | 88.50% | |
A24 | 50 | 147 | 196 | 196 | 97.00% | |
A34 | 258 | 554 | 800 | 795 | 99.20% | |
A21 | 72 | 203 | 275 | 273 | 96.30% | |
A17 | 155 | 377 | 523 | 522 | 100% | |
AVERAGE | 95.04% | |||||
| ||||||
Patient | # coding indels | # indels from mutation clusters | # total unique indels | # indels with coverage* | % somatic | |
| ||||||
indels | A10 | 11 | 145 | 156 | 155 | 80.70% |
A22 | 9 | 74 | 80 | 79 | 78.50% | |
A29 | 6 | 44 | 49 | 49 | 87.80% | |
A31 | 5 | 48 | 52 | 51 | 82.40% | |
A32 | 11 | 93 | 101 | 100 | 86% | |
A12 | 14 | 76 | 84 | 83 | 86.80% | |
A24 | 9 | 66 | 73 | 72 | 83.30% | |
A34 | 43 | 258 | 284 | 282 | 96.10% | |
A21 | 9 | 85 | 89 | 88 | 81.80% | |
A17 | 15 | 123 | 123 | 122 | 99.20% | |
AVERAGE | 86.26% | |||||
| ||||||
Patient | # rearrs validated | PCR failed | % somatic | |||
| ||||||
Rearrangements | A22 | 49 | 21 | 57% (82% with rearrs confirmed by the visual inspection of copy number changes) | ||
A31 | 21 | 1 | 95% | |||
A32 | 32 | 1 | 96% | |||
A24 | 27 | 3 | 89% |